When I went after BPC-157, I was talking about a specific molecule, sold through gray market suppliers and unregulated compounding pharmacies, that people are injecting subcutaneously into their muscle tissue, into their joints based on animal data from a single research group in Zagreb
Within peptide and recovery-focused research models, this combination is referenced in studies involving tissue-repair mechanisms, angiogenesis modelling, and cellular-response investigation
Its primary mechanism is angiogenesis: BPC-157 helps trigger new blood vessel growth in injured tissue, which is what allows it to support repair in tendons, ligaments, the gut lining, and joints
The dermis (the thick middle layer of skin) is composed of a complex network called the extracellular matrix, or ECM
While clinical trials in humans remain limited, the consistent findings across animal models offer a compelling basis for future investigation into its application in gut health contexts